Holdren Defends NSF Grant Review

Presidential science advisor argues against draft legislation that would change how the National Science Foundation judges grant proposals.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

John Holdren, science advisor to President ObamaWIKIMEDIA, NASA/BILL INGALLSJohn Holdren, the senior science advisor to President Barack Obama, has defended basic research and strongly criticized a draft bill that would revise the criteria used by the National Science Foundation (NSF) to review grant applications, reported ScienceInsider.

Drawn up by Lamar Smith (R-TX), chair of the House of Representatives science committee, the proposed “High-Quality Research Act” would require the NSF to prioritize projects that “advance the national health, prosperity, and welfare” of the United States, that are “groundbreaking,” and that are not already supported by another federal agency. The NSF currently judges grant proposals based on their “intellectual merit” and on the “broader implications” of the research on society. In an April 30 statement, Smith said that is legislation would improve on that process “by adding a layer of accountability” to the taxpayer.

But Holdren, speaking last week (May 2) at the Science and Technology Policy Forum in Washington, D.C., argued that by requiring the NSF to predict the future impact of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies